Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same

• US 7,235,360 B2
• Filed: 04/06/2004
• Issued: 06/26/2007
• Est. Priority Date: 03/14/1997
• Status: Expired due to Fees

• Current Assignee: IDEC Pharmaceuticals Corporation (Biogen, Inc.)
• Original Assignee: Biogen, Inc.
• Inventors: Reff, Mitchell R., McLachlan, Karen Retta, Barnett, Richard Spence
• Primary Examiner(s): Brusca; John S.
• Application Number:
  US10/817,950
• Publication Number:
  US 20040166528A1
• Time in Patent Office: 1,176 Days
• Field of Search: None
• US Class Current: 435/6.13
• CPC Class Codes: C07K 14/70521 CD28, CD152
• CPC Class Codes: C07K 16/2851 against the lectin superfamily, e.g. CD23, CD72
• CPC Class Codes: C07K 16/2896 against molecules with a "CD"-designation, not provided for elsewhere
• CPC Class Codes: C07K 2319/02 containing a signal sequence
• CPC Class Codes: C12N 15/85 for animal cells
• CPC Class Codes: C12N 15/907 in mammalian cells
• CPC Class Codes: C12N 2800/108 episomal vectors
• CPC Class Codes: C12N 2830/42 being an intron or intervening sequence for splicing and/or stability of RNA
• CPC Class Codes: C12N 2840/20 translation of more than one cistron
• CPC Class Codes: C12N 2840/44 being a specific part of the splice mechanism, e.g. donor, acceptor

Abstract

A method for achieving site specific integration of a desired DNA at a target site in a mammalian cell via homologous recombination is described. This method provides for the reproducible selection of cell lines wherein a desired DNA is integrated at a predetermined transcriptionally active site previously marked with a marker plasmid. The method is particularly suitable for the production of mammalian cell lines which secrete mammalian proteins at high levels, in particular immunoglobulins. Novel vectors and vector combinations for use in the subject cloning method are also provided.

Claims

1. A method for inserting a desired DNA at a target site in the genome of a mammalian cell which comprises the following steps:

(i) transfecting or transforming a mammalian cell in vitro with a marker plasmid comprising the following sequences;

(a) a first DNA fragment which comprises a region that is heterologous to the mammalian cell genome and provides a unique site for homologous recombination when it is integrated in the mammalian cell genome;

(b) a second DNA fragment which comprises at least one exon but not all of the exons of a gene encoding a first selectable marker protein; and

(c) a third DNA fragment which comprises a region encoding a second selectable marker protein that is different from the first selectable protein and provides for selection of a mammalian cell which has said marker plasmid integrated into its genome;

(ii) selecting a cell which contains the marker plasmid integrated in its genome by screening in vitro for expression of a selectable marker protein encoded by said third DNA fragment;

(iii) transfecting or transforming said selected cell with a target plasmid which comprises at least one DNA to be inserted into the genome of said cell, and further comprises the following sequences;

(a) a fourth DNA fragment which comprises a region that is identical or is sufficiently homologous to the unique site for homologous recombination in the marker plasmid such that this region can recombine with said marker plasmid DNA via homologous recombination; and

(b) a fifth DNA fragment which comprises the remaining exon or exons of the gene encoding a first selectable marker protein that are not present in the marker plasmid;

wherein an active first selectable marker protein is only produced if the at least one exon of a gene encoding a first selectable marker protein contained in the marker plasmid is expressed in association with the remaining exon or exons of the gene encoding a first selectable marker protein contained in the target plasmid; and

(iv) selecting cells which contain the target plasmid integrated at the unique site for homologous recombination by screening in vitro for the expression of the first selectable marker protein.

2. The method of claim 1, wherein the at least one DNA to be inserted into the genome of said cell encodes a desired protein.

3. The method of claim 2, wherein the desired protein is a mammalian protein.

4. The method of claim 3, wherein the mammalian protein is an immunoglobulin.

5. The method of claim 1, wherein the at least one DNA to be inserted into the genome of said cell is inserted adjacent to an exon of said first selectable marker contained in the target plasmid.

6. The method of claim 1, wherein the first selectable marker protein is selected from the group consisting of neomycin phosphotransferase, histidinol dehydrogenase, dihydrofolate reductase, hygromycin phosphotransferase, herpes simplex virus thymidine kinase, adenosine deaminase, glutamine synthetase, and hypoxanthine-guanine phosphoribosyl transferase.

7. The method of claim 6, wherein the at least one exon of the gene encoding the first selectable marker protein in the marker plasmid contains a portion of a neomycin phosphotransferase gene, and the remaining exons in the target plasmid contain the remaining portions of said neomycin phosphotransferase gene.

8. The method of claim 1, which further comprises determining the RNA levels of the second selectable marker contained in said third DNA fragment of the marker plasmid prior to integration of the target vector.

9. The method of claim 1, wherein the second selectable marker protein which is different from said first selectable marker protein is selected from the group consisting of neomycin phosphotransferase, histidinol dehydrogenase, dihydrofolate reductase, hygromycin phosphotransferase, herpes simplex virus thymidine kinase, adenosine deaminase, glutamine synthetase, and hypoxanthine guanine phosphoribosyl transferase.

10. The method of claim 1, wherein the marker or the target plasmid further comprises a DNA encoding a third selectable marker protein that is different from the first and second selectable marker proteins.

11. The method claim 10, wherein expression of the DNA encoding a third selectable marker protein permits amplification of said DNA to be inserted into the genome of said cell.

12. The method claim 11, wherein the third selectable marker protein is dihydrofolate reductase.

13. The method of claim 1, wherein the mammalian cell is selected from the group consisting of Chinese hamster ovary (CHO) cells, myeloma cells, baby hamster kidney cells, COS cells, NSO cells, HeLa cells and NIH 3T3 cells.

14. The method of claim 13, wherein the cell is a CHO cell.

15. The method of claim 1, wherein the marker plasmid further contains a rare restriction endonuclease sequence which is inserted within the region of DNA in the first DNA fragment of the marker plasmid that provides a unique site for homologous recombination.

16. The method of claim 1, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination is at least 300 nucleotides.

17. The method of claim 16, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination ranges in size from about 300 nucleotides to 20 kilobases.

18. The method of claim 17, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination ranges in size from 2 to 10 kilobases.

19. The method of claim 1, wherein the DNA encoding the first selectable marker protein is split into at least three exons.

20. The method of claim 1, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination is a bacterial DNA, an insect DNA, a viral DNA or a synthetic DNA.

21. The method of claim 20, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination does not contain any functional genes.

22. A vector system for inserting a desired DNA at a target site in the genome of a mammalian cell in vitro which comprises at least the following:

(i) a marker plasmid comprising the following sequences;

(a) a first DNA fragment which comprises a region of DNA that is heterologous to the mammalian cell genome and provides a unique site for homologous recombination when it is integrated in the mammalian cell genome;

(b) a second DNA fragment which comprises at least one exon but not all of the exons of a gene encoding a first selectable marker protein; and

(c) a third DNA fragment which comprises a region encoding a second selectable marker protein that is different from the first selectable protein and provides for selection of a mammalian cell in vitro which has said marker plasmid integrated into its genome; and

(ii) a target plasmid which comprises at least one DNA to be inserted into the genome of said cell, and further comprises the following sequences;

(a) a fourth DNA fragment which comprises a region that is identical or is sufficiently homologous to the unique site for homologous recombination in the marker plasmid such that this region of DNA can recombine with said marker plasmid DNA via homologous recombination;

(b) a fifth DNA fragment which comprises the remaining exon or exons of the gene encoding a first selectable marker protein that are not present in the marker plasmid;

wherein the at least one exon of a gene encoding a first selectable marker protein in the marker plasmid and the remaining exon or exons of the gene encoding a first selectable marker protein in the target plasmid together encode an active first selectable marker protein.

23. The vector system of claim 22, wherein the at least one DNA to be inserted into the genome of said cell encodes a desired protein.

24. The vector system of claim 23, wherein the desired protein is a mammalian protein.

25. The vector system of claim 24, wherein the mammalian protein is an immunoglobulin.

26. The vector system of claim 22, wherein the at least one DNA to be inserted into the genome of said cell is inserted adjacent to an exon of said first selectable marker contained in the target plasmid.

27. The vector system of claim 22, wherein the first selectable marker protein is selected from the group consisting of neomycin phosphotransferase, histidinol dehydrogenase, dihydrofolate reductase, hygromycin phosphotransferase, herpes simplex virus thymidine kinase, adenosine deaminase, glutamine synthetase, and hypoxanthine guanine phosphoribosyl transferase.

28. The vector system of claim 27, wherein the at least one exon of the gene encoding the first selectable marker protein in the marker plasmid contains a portion of a neomycin phosphotransferase gene, and the remaining exons in the target plasmid contain the remaining portions of said neomycin phosphotransferase gene.

29. The vector system of claim 22, wherein the second selectable marker protein which is different from said first selectable marker protein is selected from the group consisting of neomycin phosphotransferase, histidinol dehydrogenase, dihydrofolate reductase, hygromycin phosphotransferase, herpes simplex virus thymidine kinase, adenosine deaminase, glutamine synthetase, and hypoxanthine guanine phosphoribosyl transferase.

30. The vector system of claim 22, wherein the marker or the target plasmid further comprises a DNA encoding a third dominant selectable marker protein that is different from the first and second selectable marker proteins.

31. The vector system of claim 30, wherein expression of the DNA encoding a third selectable marker protein permits amplification of said DNA to be inserted into the genome of said cell.

32. The vector system of claim 31, wherein the third selectable marker protein is dihydrofolate reductase.

33. The vector system of claim 22, which provides for insertion of a desired DNA at a targeted site in the genome of a mammalian cell selected from the group consisting of Chinese hamster ovary (CHO) cells, myeloma cells, baby hamster kidney cells, COS cells, NSO cells, HeLa cells and NIH 3T3 cells.

34. The vector system of claim 33, wherein the mammalian cell is a CHO cell.

35. The vector system of claim 22, wherein the marker plasmid further contains a rare restriction endonuclease sequence which is inserted within the region of DNA in the first DNA fragment of the marker plasmid that provides a unique site for homologous recombination.

36. The vector system of claim 22, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination is at least 300 nucleotides.

37. The vector system of claim 36, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination ranges in size from about 300 nucleotides to 20 kilobases.

38. The vector system of claim 37, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination ranges in size from 2 to 10 kilobases.

39. The vector system of claim 22, wherein the DNA encoding the first selectable marker protein is split into at least three exons.

40. The vector system of claim 22, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination is a bacterial DNA, an insect DNA, a viral DNA or a synthetic DNA.

41. The vector system of claim 40, wherein the region of DNA in the first DNA fragment that provides a unique site for homologous recombination does not contain any functional genes.